Danielle L Sanchez1, Kelsey R Thomas2,3, Emily C Edmonds2,3, Mark W Bondi2,4, Katherine J Bangen2,3. 1. Department of Psychology, San Diego State University, San Diego, CA, USA. 2. Research Service, VA San Diego Healthcare System, San Diego, CA, USA. 3. Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA. 4. Psychology Service, VA San Diego Healthcare System, San Diego, CA, USA.
Abstract
BACKGROUND: Increasing evidence indicates that cerebrovascular dysfunction may precede cognitive decline in aging and Alzheimer's disease (AD). Reduced cerebral blood flow (CBF) is associated with cognitive impairment in older adults. However, less is known regarding the association between CBF and functional decline, and whether CBF predicts functional decline beyond cerebrovascular and metabolic risk factors. OBJECTIVE: To examine the association between regional CBF and functional decline in nondemented older adults. METHOD: One hundred sixty-six (N = 166) participants without dementia from the Alzheimer's Disease Neuroimaging Initiative underwent neuropsychological testing and neuroimaging. Pulsed arterial spin labeling magnetic resonance imaging was acquired to quantify resting CBF. Everyday functioning was measured using the Functional Assessment Questionnaire at baseline and annual follow-up visit across three years. RESULTS: Adjusting for age, education, sex, cognitive status, depression, white matter hyperintensity volume, cerebral metabolism, and reference (precentral) CBF, linear mixed effects models showed that lower resting CBF at baseline in the medial temporal, inferior temporal, and inferior parietal lobe was significantly associated with accelerated decline in everyday functioning. Results were similar after adjusting for conventional AD biomarkers, including cerebrospinal fluid (CSF) amyloid-β (Aβ) and hyperphosphorylated tau (p-tau) and apolipoprotein E (APOE) ɛ4 positivity. Individuals who later converted to dementia had lower resting CBF in the inferior temporal and parietal regions compared to those who did not. CONCLUSION: Lower resting CBF in AD vulnerable regions including medial temporal, inferior temporal, and inferior parietal lobes predicted faster rates of decline in everyday functioning. CBF has utility as a biomarker in predicting functional declines in everyday life and conversion to dementia.
BACKGROUND: Increasing evidence indicates that cerebrovascular dysfunction may precede cognitive decline in aging and Alzheimer's disease (AD). Reduced cerebral blood flow (CBF) is associated with cognitive impairment in older adults. However, less is known regarding the association between CBF and functional decline, and whether CBF predicts functional decline beyond cerebrovascular and metabolic risk factors. OBJECTIVE: To examine the association between regional CBF and functional decline in nondemented older adults. METHOD: One hundred sixty-six (N = 166) participants without dementia from the Alzheimer's Disease Neuroimaging Initiative underwent neuropsychological testing and neuroimaging. Pulsed arterial spin labeling magnetic resonance imaging was acquired to quantify resting CBF. Everyday functioning was measured using the Functional Assessment Questionnaire at baseline and annual follow-up visit across three years. RESULTS: Adjusting for age, education, sex, cognitive status, depression, white matter hyperintensity volume, cerebral metabolism, and reference (precentral) CBF, linear mixed effects models showed that lower resting CBF at baseline in the medial temporal, inferior temporal, and inferior parietal lobe was significantly associated with accelerated decline in everyday functioning. Results were similar after adjusting for conventional AD biomarkers, including cerebrospinal fluid (CSF) amyloid-β (Aβ) and hyperphosphorylated tau (p-tau) and apolipoprotein E (APOE) ɛ4 positivity. Individuals who later converted to dementia had lower resting CBF in the inferior temporal and parietal regions compared to those who did not. CONCLUSION: Lower resting CBF in AD vulnerable regions including medial temporal, inferior temporal, and inferior parietal lobes predicted faster rates of decline in everyday functioning. CBF has utility as a biomarker in predicting functional declines in everyday life and conversion to dementia.
Entities:
Keywords:
Activities of daily living; Alzheimer’s disease; aging; biomarkers; cerebrovascular circulation; dementia; magnetic resonance imaging; neuropsychology; perfusion; regional blood flow
Authors: Jill B De Vis; Shin-Lei Peng; Xi Chen; Yang Li; Peiying Liu; Sandeepa Sur; Karen M Rodrigue; Denise C Park; Hanzhang Lu Journal: J Magn Reson Imaging Date: 2018-01-02 Impact factor: 4.813
Authors: A T Du; G H Jahng; S Hayasaka; J H Kramer; H J Rosen; M L Gorno-Tempini; K P Rankin; B L Miller; M W Weiner; N Schuff Journal: Neurology Date: 2006-10-10 Impact factor: 9.910
Authors: Adam M Staffaroni; Yann Cobigo; Fanny M Elahi; Kaitlin B Casaletto; Samantha M Walters; Amy Wolf; Cutter A Lindbergh; Howard J Rosen; Joel H Kramer Journal: Hum Brain Mapp Date: 2019-05-07 Impact factor: 5.038
Authors: Katherine J Bangen; Kelsey R Thomas; Alexandra J Weigand; Danielle L Sanchez; Lisa Delano-Wood; Emily C Edmonds; Owen T Carmichael; Christopher G Schwarz; Adam M Brickman; Mark W Bondi Journal: Neurobiol Aging Date: 2019-11-02 Impact factor: 4.673
Authors: Katherine J Bangen; Madeleine L Werhane; Alexandra J Weigand; Emily C Edmonds; Lisa Delano-Wood; Kelsey R Thomas; Daniel A Nation; Nicole D Evangelista; Alexandra L Clark; Thomas T Liu; Mark W Bondi Journal: Front Aging Neurosci Date: 2018-09-10 Impact factor: 5.750
Authors: Kelsey R Thomas; Alexandra J Weigand; Isabel H Cota; Emily C Edmonds; Christina E Wierenga; Mark W Bondi; Katherine J Bangen Journal: Brain Imaging Behav Date: 2021-08-20 Impact factor: 3.224
Authors: Natalie Terzikhan; Lies Lahousse; Sara R A Wijnant; Daniel Bos; Guy Brusselle; Maxim Grymonprez; Ernst Rietzschel; Meike W Vernooij Journal: BMJ Open Date: 2021-12-17 Impact factor: 2.692